Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary purpose of this study is evaluate the VRI device's accuracy in diagnosis of pleural effusion (in comparison to chest x-ray and ultrasonography), and to assess the pleural effusion location and size. The VRI system uses pressure sensors (electronic stethoscopes) to record the energy created by the airflow in the lungs during breathing.
| Condition |
|---|
|
Pleural Effusion |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion |
| Estimated Enrollment: | 80 |
| Study Start Date: | November 2006 |
| Study Completion Date: | December 2007 |
| Groups/Cohorts |
|---|
|
Patients with pleural effusion
Patients diagnosed with pleural effusion and presenting for treatment
|
Detailed Description:
The accumulation of excess fluid in the pleural cavity of the lungs, known as pleural effusion, is a common clinical condition that may be the result of trauma or disease. Diagnosis and management of pleural effusion can be done by X-Ray or ultrasound; however X-Ray emits radiation, requires a special room and expert personnel, while ultrasound requires a high level of expertise to perform and analyze. The VRI device is non-invasive and radiation free. The VRI device is a simple method to image the lungs in a regional manner to examine changes that occur during pleural effusion.
Comparison: X-ray and ultrasonography evaluations of pleural effusion, compared to VRI acoustic imaging evaluations.
Eligibility| Ages Eligible for Study: | 18 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients diagnosed with pleural effusion
Inclusion Criteria:
- Able and willing to read, understand, and provide written Informed Consent;
- Male or Female in the age range of 18-85 years;
- Subject is suspected to have pleural effusion;
- Body mass index (BMI) > 21.
Exclusion Criteria:
- Chest wall deformation;
- Spine deformation (including severe scoliosis);
- Hirsutism;
- Potentially contagious skin lesion on the back;
- Skin lesion that would interfere with sensor placement;
- Cardiac pacemaker or implantable defibrillator;
Contacts and Locations| United States, Massachusetts | |
| Beth Israel Deaconess Medical Center, Harvard Medical School | |
| Boston, Massachusetts, United States, 02215 | |
| Principal Investigator: | Armin Ernst, M.D. | Beth Israel Deaconess Medical Center |
More Information
Publications:
| Responsible Party: | Merav Gat/VP Clinical Affairs, Deep Breeze |
| ClinicalTrials.gov Identifier: | NCT00473291 History of Changes |
| Other Study ID Numbers: | DB029 |
| Study First Received: | May 14, 2007 |
| Last Updated: | June 15, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Deep Breeze:
|
pleural effusion lung sounds acoustic monitoring |
Additional relevant MeSH terms:
|
Pleural Effusion Pleural Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 17, 2013